Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Psyched Wellness Ltd (OP: PSYCF )

0.0417 +0.0025 (+6.38%)
Streaming Delayed Price Updated: 2:47 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,500
Open 0.0417
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0392
Today's Range 0.0417 - 0.0417
52wk Range 0.0224 - 0.0833
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety 
Via Benzinga
EXCLUSIVE: Psychedelics Co. Closes $7.5M Financing - Here's Its Secret To Raising Millions In A Tough Environment
In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+27.91%
+27.91%
1 Month
+22.65%
+22.65%
3 Month
+17.46%
+17.46%
6 Month
+15.83%
+15.83%
1 Year
-0.24%
-0.24%

More News

Read More
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Via Benzinga
Amanita Muscaria Mushrooms Are Taking The Lead In Markets As Research Ramps Up
Via Benzinga
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
Via Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
Via Benzinga
Legal Mushroom Products From Amanita Muscaria Shipped To 37 US States
Via Benzinga
Amanita Muscaria Mushroom-Based Products Now Offered Online By Psyched Wellness
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Via Benzinga
Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage
Via Benzinga
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Via Benzinga
Psyched Wellness CEO Buys This Many Shares In The Open Market
Via Benzinga
Core One Labs Begins Trading On OTCQB
Via Benzinga
The Power Play by The Market Herald Releases New Interviews with Filament Health, Kidoz Inc., Falcon Gold, Psyched Wellness, Maven Brands Inc., and Xali Gold Corp.
From The Market Herald
Via AccessWire
Topics Cannabis
Exposures Cannabis Product Safety
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Via Benzinga
Psyched Wellness Announces Participation in the H.C. Wainwright 23rd Annual Global Investment Conference
Via Newsfile
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Via Benzinga
Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1
Via Newsfile
Topics Cannabis
Exposures Cannabis
CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market
Via Newsfile
Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
BTV Examines the Rapidly Expanding Psychedelics Market
Via Newsfile
Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to Asia
Via Newsfile
Amanda Galbraith, Principal at Navigator Joins the Board of Psyched Wellness
Via Newsfile
Psyched Wellness Receives Positive Results from It's 14-Day Oral Toxicity Preclinical Study
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.